IRIS
RUSSO, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.425
EU - Europa 2.112
AS - Asia 1.952
SA - Sud America 459
AF - Africa 364
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 8.342
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.330
SG - Singapore 966
CN - Cina 644
RU - Federazione Russa 643
IT - Italia 638
BR - Brasile 394
CI - Costa d'Avorio 264
IE - Irlanda 254
DE - Germania 142
VN - Vietnam 93
FI - Finlandia 83
KR - Corea 82
CA - Canada 75
UA - Ucraina 70
FR - Francia 50
AT - Austria 46
SN - Senegal 42
GB - Regno Unito 39
NL - Olanda 39
TR - Turchia 34
AR - Argentina 26
AU - Australia 21
SE - Svezia 19
BD - Bangladesh 18
CZ - Repubblica Ceca 18
IN - India 18
BE - Belgio 16
BJ - Benin 14
NG - Nigeria 14
IR - Iran 12
EC - Ecuador 11
PL - Polonia 11
ZA - Sudafrica 11
MX - Messico 10
UZ - Uzbekistan 10
CO - Colombia 9
JP - Giappone 9
PK - Pakistan 9
PT - Portogallo 9
ID - Indonesia 8
IQ - Iraq 8
ES - Italia 7
TW - Taiwan 7
VE - Venezuela 7
CH - Svizzera 6
KE - Kenya 6
AE - Emirati Arabi Uniti 5
BG - Bulgaria 5
GR - Grecia 5
KZ - Kazakistan 5
NZ - Nuova Zelanda 5
EG - Egitto 4
HK - Hong Kong 4
HU - Ungheria 4
LB - Libano 4
TN - Tunisia 4
CR - Costa Rica 3
IL - Israele 3
KG - Kirghizistan 3
LT - Lituania 3
PY - Paraguay 3
BO - Bolivia 2
CL - Cile 2
ET - Etiopia 2
JM - Giamaica 2
JO - Giordania 2
NO - Norvegia 2
NP - Nepal 2
PE - Perù 2
PS - Palestinian Territory 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AQ - Antartide 1
AZ - Azerbaigian 1
BB - Barbados 1
BY - Bielorussia 1
DZ - Algeria 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GF - Guiana Francese 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
NI - Nicaragua 1
OM - Oman 1
RO - Romania 1
SA - Arabia Saudita 1
SV - El Salvador 1
TG - Togo 1
Totale 8.342
Salva come PNG Salva come JPEG
Città #
Dallas 697
Singapore 577
Santa Clara 526
Chandler 435
Moscow 304
Abidjan 264
Dublin 244
Chicago 181
Hefei 177
Catania 169
Ashburn 114
Houston 111
Beijing 109
Boardman 105
Los Angeles 85
Seoul 82
Jacksonville 69
Civitanova Marche 63
Nuremberg 63
Cambridge 61
Lawrence 61
Andover 55
Helsinki 43
Dakar 42
Nanjing 38
Lappeenranta 36
Des Moines 34
Rome 32
Toronto 28
Vienna 28
Bremen 27
São Paulo 27
Ho Chi Minh City 26
New York 25
Wilmington 23
Buffalo 22
Hanoi 22
Munich 22
Pozzallo 19
Dong Ket 18
Falls Church 18
Kayseri 18
Ottawa 17
Brno 16
Columbus 16
Council Bluffs 16
Acireale 15
Brussels 15
The Dalles 15
Abuja 14
Cotonou 14
Nanchang 14
Shanghai 14
Saint Petersburg 13
Amsterdam 12
Naples 12
Rio de Janeiro 12
Belo Horizonte 11
Denver 11
Melbourne 11
Montreal 11
San Giovanni la Punta 11
Boston 10
Grafing 10
Tianjin 10
Warsaw 10
Atlanta 9
Mascalucia 9
Palermo 9
Salvador 9
Seattle 9
Tehran 9
Campinas 8
Messina 8
Redondo Beach 8
San Mateo 8
Changsha 7
Chennai 7
Curitiba 7
Hebei 7
L'Île-Saint-Denis 7
Padova 7
Phoenix 7
Reggio Calabria 7
San Francisco 7
Tokyo 7
Turin 7
Zhengzhou 7
Brooklyn 6
Fortaleza 6
Jiaxing 6
Nairobi 6
New Taipei City 6
Porto Alegre 6
Ragusa 6
Stockholm 6
Ankara 5
Bari 5
Bologna 5
Brasília 5
Totale 5.648
Salva come PNG Salva come JPEG
Nome #
((2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist 291
2DIs: a SBML compliant web platform for the design and modeling of immune system interactions 165
A MapReduce Based Tool for the Analysis and Discovery of Novel Therapeutic Targets 160
A Credibility Assessment Plan for an In Silico Model that Predicts the Dose-Response Relationship of New Tuberculosis Treatments 158
Computational modelling in melanoma for novel drug discovery 156
Computational modeling of immunologic response to immune checkpoint inhibitors in COVID-19 patients with and without cancer 145
Agent based modeling of the immune system: NetLogo, a promising framework 144
Agent based modeling of the effects of potential treatments over the blood-brain barrier in multiple sclerosis 143
A multi-step and multi-scale bioinformatic protocol to investigate potential SARS-CoV-2 vaccine targets 139
R- ed S-LP2: sintesi, molecular docking e valutazione farmacologica 137
Agent based modeling of relapsing multiple sclerosis: A possible approach to predict treatment outcome 137
Computational modeling of PI3K/AKT and MAPK signaling pathways in melanoma cancer 136
A MapReduce tool for in-depth analysis of KEGG pathways: identification and visualization of therapeutic target candidates 135
A computational model to predict the immune system activation by citrus derived vaccine adjuvants 133
Boosting multiple sclerosis lesion segmentation through attention mechanism 132
An agent based modeling approach for the analysis of tuberculosis - Immune system dynamics 125
The Potential of Computational Modeling to Predict Disease Course and Treatment Response in Patients with Relapsing Multiple Sclerosis 125
Combining agent based-models and virtual screening techniques to predict the best citrus-derived vaccine adjuvants against human papilloma virus 119
EpiMethEx: a tool for large-scale integrated analysis in methylation hotspots linked to genetic regulation 118
Advancing PFAS risk assessment: Integrative approaches using agent-based modelling and physiologically-based kinetic for environmental and health safety 117
In silico clinical trials: concepts and early adoptions 116
DNA methylation and gene expression in melanoma: A large-scale integrated analysis 115
Gene Silencing of Transferrin-1 Receptor as a Potential Therapeutic Target for Human Follicular and Anaplastic Thyroid Cancer 114
Gene expression and pathway bioinformatics analysis detect a potential predictive value of MAP3K8 in thyroid cancer progression 110
PEAK: A Clever Python Tool for Exploratory, Regression, and Classification Data. A Case Study for COVID-19 109
Beyond the state of the art of reverse vaccinology: predicting vaccine efficacy with the universal immune system simulator for influenza 108
Predicting the artificial immunity induced by RUTI® vaccine against tuberculosis using universal immune system simulator (UISS) 106
In silico design of recombinant multi-epitope vaccine against influenza A virus 104
Combining Parallel Genetic Algorithms and Machine Learning to Improve the Research of Optimal Vaccination Protocols 103
Computational modeling reveals MAP3K8 as mediator of resistance to vemurafenib in thyroid cancer stem cells 103
Moving forward through the in silico modeling of tuberculosis: a further step with UISS-TB 101
Enhancing Multiple Sclerosis Lesion Segmentation in Multimodal MRI Scans with Diffusion Models 99
BIOESOnet: A Tool for the Generation of Personalized Human Metabolic Pathways from 23andMe Exome Data 99
Design and optimization of PEGylated nanoparticles intended for Berberine Chloride delivery 98
Credibility of In Silico Trial Technologies - A Theoretical Framing 97
A multi-step and multi-scale bioinformatic approach to investigate potential source of cross-reactive immunity against SARS-CoV-2 UK variant 97
Evaluation of the efficacy of RUTI and ID93/GLA-SE vaccines in tuberculosis treatment: in silico trial through UISS-TB simulator 95
Computational models to predict disease course and treatment response in multiple sclerosis 94
Toward computational modelling on immune system function 93
Computational identification of differentially-expressed genes as suggested novel COVID-19 biomarkers: A bioinformatics analysis of expression profiles 91
GPU accelerated analysis of treg-teff cross regulation in relapsing-remitting multiple sclerosis 91
Computational modeling of the expansion of human cord blood CD133+ hematopoietic stem/progenitor cells with different cytokine combinations 89
Reverse Vaccinology for Influenza A Virus: From Genome Sequencing to Vaccine Design 87
Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review) 86
PETAL: A Python tool for deep analysis of biological pathways 86
Using Continuous Petri Nets to predict the impact of microRNA analysis in PI3K/Akt and MAPK Signaling Pathways 85
In silico evaluation of daclizumab and vitamin D effects in multiple sclerosis using agent based models 83
Model verification tools: a computational framework for verification assessment of mechanistic agent-based models 82
How can we accelerate COVID-19 vaccine discovery? 82
Computational modelling and simulation for immunotoxicity prediction induced by skin sensitisers 80
Genetic Algorithm-Based Prediction of Emerging SARS-CoV-2 Variants: A Computational Biology Perspective 80
Modeling Cutaneous Leishmaniasis: Insights into M1/M2 Macrophage Dynamics Using the Universal Immune System Simulator 80
Cutaneous Leishmaniasis: discovering new effective therapies using the Universal Immune System Simulator 79
Introducing scale factor adjustments on agent-based simulations of the immune system 79
Generation of digital patients for the simulation of tuberculosis with UISS-TB 78
MSLesSeg: baseline and benchmarking of a new Multiple Sclerosis Lesion Segmentation dataset 77
Moving forward through the in silico modeling of multiple sclerosis: Treatment layer implementation and validation 75
Modeling biology spanning different scales: An open challenge 73
The combination of artificial intelligence and systems biology for intelligent vaccine design 73
Uncertainty quantification and sensitivity analysis for in silico trial platform: A preliminary application on UISS-MS 73
Toward a Regulatory Pathway for the Use of in Silico Trials in The Ce Marking of Medical Devices 72
Computational modelling approaches to vaccinology 72
Optimization and analisys of vaccination schedules using simulated annealing and agent based models 72
Computational immunogenetics 72
ODEs approaches in modeling fibrosis. Comment on "Towards a unified approach in the modeling of fibrosis: A review with research perspectives" by Martine Ben Amar and Carlo Bianca 71
Text mining and word embedding for classification of decision making variables in breast cancer surgery 70
Translatability and transferability of in silico models: Context of use switching to predict the effects of environmental chemicals on the immune system 68
Predictive Modelling of Allergic Responses to Chemical Sensitizers: Distinguishing Skin and Respiratory Reactions 68
Universal Immune System Simulator Analysis: The Impact of the Variable Approach Technique® on Enhancing Immune Defense Against infectious diseases 64
Possible Contexts of Use for In Silico trials methodologies: a consensus- based review 63
Pioneering bioinformatics with agent-based modelling: an innovative protocol to accurately forecast skin or respiratory allergic reactions to chemical sensitizers 63
Genetic algorithm application for the prediction of potential SARS-CoV-2 new variant of concern 61
Exploiting Stochastic Petri Net formalism to capture the Relapsing Remitting Multiple Sclerosis variability under Daclizumab administration 61
Modeling and Simulation of anakinra effects on severe COVID19 Patients 60
Modeling PI3K/PDK1/Akt and MAPK Signaling Pathways using Continuous Petri Nets 60
Generation of digital patients for the simulation of tuberculosis with UISS-TB 60
Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibility 60
Quality by design tools reducing the gap from bench to bedside for nanomedicine 58
In silico trial to test COVID-19 candidate vaccines: a case study with UISS platform 56
Machine Learning techniques application to predict the quality of life degree in breast cancer patients 56
Novel computational strategies for the identification of new therapeutic targets in melanoma and thyroid cancer. 55
Computational modeling approach to suggest possible therapeutic interventions in spinal muscular atrophy 54
UISS-GPU: Accelerated In-Silico Tuberculosis Vaccine Trials Using FLAME GPU 52
Comment on “A decade of thermostatted kinetic theory models for complex active matter living systems” by Carlo Bianca 51
In silico clinical trials for relapsing-remitting multiple sclerosis with MS TreatSim 51
Evaluation of word embedding models to extract and predict surgical data in breast cancer 51
Model Credibility 50
Verification of an agent-based disease model of human Mycobacterium tuberculosis infection 45
In vitro approaches to investigate the effect of chemicals on antibody production: the case study of PFASs 43
Toward computational modelling on immune system function 43
Model Development 42
Modeling, simulation and prediction of protein structures for the design of oncolytic viruses 42
A Head-to-Head Evaluation of a Novel Universal Influenza Vaccine Against Current Formulation: Implications for Future Immunization Strategies 38
Unintended Risks of mRNA COVID-19 Vaccines: A UISS Simulation Study on Immune and Organ Health 30
Exploring SARS-CoV-2 spike protein mutations through genetic algorithm-driven structural modeling 22
Breaking the Cycle: Advancements in Universal Influenza Vaccine Design 20
Verify: A toolbox for deterministic verification of computational models 15
When Bioinformatics Meets Agent-Based Modeling: An Evolving Paradigm for Complex Biological Systems 7
null 1
Totale 8.584
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.962
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.962
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021153 0 0 0 0 0 25 34 3 29 12 19 31
2021/2022479 48 57 4 13 84 9 62 26 35 20 14 107
2022/20231.111 72 81 23 163 98 173 7 178 217 14 39 46
2023/2024816 32 177 42 21 19 126 22 75 8 111 111 72
2024/20252.328 62 307 128 165 462 297 267 65 117 176 137 145
2025/20263.116 282 370 850 307 653 654 0 0 0 0 0 0
Totale 8.584